Year |
Citation |
Score |
2023 |
Talledge N, Yang H, Shi K, Coray R, Yu G, Arndt WG, Meng S, Baxter GC, Mendonça LM, Castaño-Díez D, Aihara H, Mansky LM, Zhang W. HIV-2 Immature Particle Morphology Provides Insights into Gag Lattice Stability and Virus Maturation. Journal of Molecular Biology. 168143. PMID 37150290 DOI: 10.1016/j.jmb.2023.168143 |
0.46 |
|
2022 |
Angert I, Karuka SR, Mansky LM, Mueller JD. Partitioning of ribonucleoprotein complexes from the cellular actin cortex. Science Advances. 8: eabj3236. PMID 35984883 DOI: 10.1126/sciadv.abj3236 |
0.508 |
|
2022 |
Yang H, Talledge N, Arndt WG, Zhang W, Mansky LM. Human immunodeficiency virus type 2 capsid protein mutagenesis reveals amino acid residues important for virus particle assembly. Journal of Molecular Biology. 167753. PMID 35868362 DOI: 10.1016/j.jmb.2022.167753 |
0.466 |
|
2022 |
Meissner ME, Talledge N, Mansky LM. Molecular Biology and Diversification of Human Retroviruses. Frontiers in Virology. 2. PMID 35783361 DOI: 10.3389/fviro.2022.872599 |
0.454 |
|
2022 |
Herrmann D, Hanson HM, Zhou LW, Addabbo R, Willkomm NA, Angert I, Mueller JD, Mansky LM, Saad JS. Molecular Determinants of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly. Journal of Molecular Biology. 167609. PMID 35490898 DOI: 10.1016/j.jmb.2022.167609 |
0.583 |
|
2021 |
Meissner ME, Willkomm NA, Lucas J, Arndt WG, Aitken SF, Julik EJ, Baliga S, Mansky LM. Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2. Journal of Molecular Biology. 434: 167355. PMID 34774569 DOI: 10.1016/j.jmb.2021.167355 |
0.527 |
|
2021 |
Meissner ME, Julik EJ, Badalamenti JP, Arndt WG, Mills LJ, Mansky LM. Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing. Viruses. 13. PMID 34372543 DOI: 10.3390/v13071338 |
0.485 |
|
2021 |
Roth M, McDaniel YZ, Daly MB, Talledge N, Greggs WM, Patterson SE, Kim B, Mansky LM. Distinct antiretroviral mechanisms elicited by a viral mutagen. Journal of Molecular Biology. 167111. PMID 34153286 DOI: 10.1016/j.jmb.2021.167111 |
0.706 |
|
2021 |
Lockbaum GJ, Henes M, Talledge N, Rusere LN, Kosovrasti K, Nalivaika EA, Somasundaran M, Ali A, Mansky LM, Kurt Yilmaz N, Schiffer CA. Inhibiting HTLV-1 Protease: A Viable Antiviral Target. Acs Chemical Biology. PMID 33619959 DOI: 10.1021/acschembio.0c00975 |
0.429 |
|
2020 |
Harris M, Ratnapriya S, Chov A, Cervera H, Block A, Gu C, Talledge N, Mansky LM, Sodroski J, Herschhorn A. Slow Receptor Binding of the Noncytopathic HIV-2 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity. Cell Reports. 31: 107749. PMID 32521274 DOI: 10.1016/J.Celrep.2020.107749 |
0.433 |
|
2020 |
Addabbo RM, Kohler J, Angert I, Mansky LM, Mueller JD. Tracking Retrovirus Particles at Different Stages of the Viral Life Cycle using 3-Dimensional Superresolution Microscopy Biophysical Journal. 118: 147a. DOI: 10.1016/J.Bpj.2019.11.923 |
0.508 |
|
2020 |
Karuka SR, Angert I, Kohler J, Mansky LM, Mueller JD. Exclusion of RNA-Associated Proteins from the Cell Cortex Observed by Dual Color z-Scan Fluorescence Microscopy Biophysical Journal. 118: 463a. DOI: 10.1016/J.Bpj.2019.11.2575 |
0.501 |
|
2019 |
Angert I, Karuka SR, Hennen J, Chen Y, Albanesi JP, Mansky LM, Mueller JD. Sensitive Detection of Protein Binding to the Plasma Membrane with Dual-Color Z-Scan Fluorescence. Biophysical Journal. PMID 31870539 DOI: 10.1016/J.Bpj.2019.12.002 |
0.613 |
|
2019 |
Shepard C, Xu J, Holler J, Kim DH, Mansky LM, Schinazi RF, Kim B. Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages. Retrovirology. 16: 29. PMID 31655617 DOI: 10.1186/S12977-019-0491-0 |
0.4 |
|
2019 |
McDaniel YZ, Patterson SE, Mansky LM. Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis. Antiviral Research. 104540. PMID 31247245 DOI: 10.1016/J.Antiviral.2019.104540 |
0.596 |
|
2019 |
Reddy Karuka S, Angert I, Kohler J, Gant Luxton G, Mansky LM, Mueller JD. Achieving Axial Super-Resolution with the Two-Photon Dual-Color Z-Scan Method Biophysical Journal. 116: 438a. DOI: 10.1016/J.Bpj.2018.11.2359 |
0.443 |
|
2019 |
Angert I, Kohler J, Reddy Karuka S, Meissner ME, Mansky LM, Mueller JD. Ultra-Sensitive Detection of Peripheral Membrane Protein Binding to the Plasma Membrane of Living Cells Biophysical Journal. 116: 283a. DOI: 10.1016/J.Bpj.2018.11.1532 |
0.506 |
|
2018 |
Eichorst JP, Chen Y, Mueller JD, Mansky LM. Distinct Pathway of Human T-Cell Leukemia Virus Type 1 Gag Punctum Biogenesis Provides New Insights into Enveloped Virus Assembly. Mbio. 9. PMID 30181245 DOI: 10.1128/Mbio.00758-18 |
0.715 |
|
2018 |
Maldonado JO, Mansky LM. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations. Viruses. 10. PMID 30029500 DOI: 10.3390/v10070376 |
0.406 |
|
2018 |
Maldonado JO, Mansky LM. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations. Viruses. 10. PMID 30029500 DOI: 10.3390/v10070376 |
0.406 |
|
2018 |
Martin JL, Mendonça L, Marusinec R, Zuczek J, Angert I, Blower RJ, Mueller JD, Perilla JR, Zhang W, Mansky LM. Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly. Journal of Virology. PMID 29695435 DOI: 10.1128/Jvi.00333-18 |
0.609 |
|
2018 |
Meissner ME, Baliga S, Roth M, Baller J, Mansky LM. A27 Exploring novel mechanisms of HIV-2 mutagenesis Virus Evolution. 4. DOI: 10.1093/ve/vey010.026 |
0.338 |
|
2017 |
Maldonado JO, Angert I, Cao S, Berk S, Zhang W, Mueller JD, Mansky LM. Perturbation of Human T-Cell Leukemia Virus Type 1 Particle Morphology by Differential Gag Co-Packaging. Viruses. 9. PMID 28753950 DOI: 10.3390/V9070191 |
0.608 |
|
2017 |
Rawson JMO, Gohl DM, Landman SR, Roth ME, Meissner ME, Peterson TS, Hodges JS, Beckman KB, Mansky LM. Single strand consensus sequencing reveals that HIV type but not subtype significantly impacts viral mutation frequencies and spectra. Journal of Molecular Biology. PMID 28502791 DOI: 10.1016/J.Jmb.2017.05.010 |
0.497 |
|
2017 |
Martin JL, Mendonça L, Angert I, Mueller JD, Zhang W, Mansky LM. Disparate contributions of human retrovirus capsid subdomains to Gag-Gag oligomerization, virus morphology and particle biogenesis. Journal of Virology. PMID 28446667 DOI: 10.1128/Jvi.00298-17 |
0.604 |
|
2016 |
Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052 |
0.685 |
|
2016 |
Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0 |
0.679 |
|
2016 |
Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15 |
0.665 |
|
2016 |
Martin JL, Maldonado JO, Mueller JD, Zhang W, Mansky LM. Molecular Studies of HTLV-1 Replication: An Update. Viruses. 8. PMID 26828513 DOI: 10.3390/V8020031 |
0.637 |
|
2016 |
Rawson JM, Clouser CL, Mansky LM. Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector. Methods in Molecular Biology (Clifton, N.J.). 1354: 71-88. PMID 26714706 DOI: 10.1007/978-1-4939-3046-3_6 |
0.423 |
|
2015 |
Zhang W, Cao S, Martin JL, Mueller JD, Mansky LM. Morphology and ultrastructure of retrovirus particles. Aims Biophysics. 2: 343-369. PMID 26448965 DOI: 10.3934/biophy.2015.3.343 |
0.595 |
|
2015 |
Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/Aac.01644-15 |
0.694 |
|
2015 |
Rawson JM, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 12: 60. PMID 26160407 DOI: 10.1186/S12977-015-0180-6 |
0.509 |
|
2015 |
Rawson JMO, Landman SR, Reilly CS, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation Retrovirology. DOI: 10.1186/s12977-015-0180-6 |
0.444 |
|
2014 |
Beach LB, Rawson JM, Kim B, Patterson SE, Mansky LM. Novel inhibitors of human immunodeficiency virus type 2 infectivity. The Journal of General Virology. 95: 2778-83. PMID 25103850 DOI: 10.1099/Vir.0.069864-0 |
0.708 |
|
2014 |
Maldonado JO, Martin JL, Mueller JD, Zhang W, Mansky LM. New insights into retroviral Gag-Gag and Gag-membrane interactions. Frontiers in Microbiology. 5: 302. PMID 25009535 DOI: 10.3389/Fmicb.2014.00302 |
0.653 |
|
2014 |
Tabah AA, Tardif K, Mansky LM. Anti-HIV-1 activity of Trim 37. The Journal of General Virology. 95: 960-7. PMID 24317724 DOI: 10.1099/vir.0.057653-0 |
0.499 |
|
2014 |
Fogarty KH, Berk S, Grigsby IF, Chen Y, Mansky LM, Mueller JD. Interrelationship between cytoplasmic retroviral Gag concentration and Gag-membrane association. Journal of Molecular Biology. 426: 1611-24. PMID 24316368 DOI: 10.1016/J.Jmb.2013.11.025 |
0.83 |
|
2014 |
Sun M, Grigsby IF, Gorelick RJ, Mansky LM, Musier-Forsyth K. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: Implications for genomic RNA packaging Journal of Virology. 88: 1271-1280. PMID 24227839 DOI: 10.1128/Jvi.02151-13 |
0.387 |
|
2014 |
Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13 |
0.842 |
|
2014 |
Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682 |
0.676 |
|
2013 |
Rawson JM, Heineman RH, Beach LB, Martin JL, Schnettler EK, Dapp MJ, Patterson SE, Mansky LM. 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8. PMID 24120088 DOI: 10.1016/J.Bmc.2013.08.023 |
0.838 |
|
2013 |
Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/Jm400653J |
0.582 |
|
2013 |
Holtz CM, Sadler HA, Mansky LM. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure. Nucleic Acids Research. 41: 6139-48. PMID 23620282 DOI: 10.1093/Nar/Gkt246 |
0.775 |
|
2013 |
Holtz CM, Mansky LM. Variation of HIV-1 mutation spectra among cell types. Journal of Virology. 87: 5296-9. PMID 23449788 DOI: 10.1128/Jvi.03576-12 |
0.805 |
|
2013 |
Dapp MJ, Patterson SE, Mansky LM. Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62. PMID 23195922 DOI: 10.1016/J.Tim.2012.10.006 |
0.839 |
|
2013 |
Dapp MJ, Heineman RH, Mansky LM. Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53. PMID 23084856 DOI: 10.1016/J.Jmb.2012.10.009 |
0.837 |
|
2012 |
Clouser CL, Chauhan J, Bess MA, van Oploo JL, Zhou D, Dimick-Gray S, Mansky LM, Patterson SE. Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorganic & Medicinal Chemistry Letters. 22: 6642-6. PMID 23010273 DOI: 10.1016/J.Bmcl.2012.08.108 |
0.703 |
|
2012 |
Dapp MJ, Holtz CM, Mansky LM. Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70. PMID 22426127 DOI: 10.1016/J.Jmb.2012.03.003 |
0.797 |
|
2012 |
Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, O'Sullivan MG, Patterson SE, Mansky LM. Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1. Antimicrobial Agents and Chemotherapy. 56: 1942-8. PMID 22271861 DOI: 10.1128/Aac.06161-11 |
0.81 |
|
2012 |
Greggs WM, Clouser CL, Patterson SE, Mansky LM. Discovery of drugs that possess activity against feline leukemia virus. The Journal of General Virology. 93: 900-5. PMID 22258856 DOI: 10.1099/Vir.0.039909-0 |
0.658 |
|
2012 |
Guenzel CA, Hérate C, Le Rouzic E, Maidou-Peindara P, Sadler HA, Rouyez MC, Mansky LM, Benichou S. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. Journal of Virology. 86: 2533-44. PMID 22171270 DOI: 10.1128/Jvi.05163-11 |
0.468 |
|
2012 |
Fogarty K, Chen Y, Grigsby I, MacDonald P, Smith E, Johnson J, Rawson J, Mansky L, Mueller J. Exploring the HTLV-1 Gag Membrane-Trafficking Pathway with Fluorescence Fluctuation Spectroscopy and Total Internal Reflection Fluorescence Microscopy Biophysical Journal. 102: 207a-208a. DOI: 10.1016/J.Bpj.2011.11.1133 |
0.797 |
|
2011 |
Fogarty KH, Zhang W, Grigsby IF, Johnson JL, Chen Y, Mueller JD, Mansky LM. New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells. Viruses. 3: 770-93. PMID 21994753 DOI: 10.3390/V3060770 |
0.814 |
|
2011 |
Greggs WM, Clouser CL, Patterson SE, Mansky LM. Broadening the use of antiretroviral therapy: the case for feline leukemia virus. Therapeutics and Clinical Risk Management. 7: 115-22. PMID 21479142 DOI: 10.2147/Tcrm.S17731 |
0.628 |
|
2011 |
Fogarty KH, Chen Y, Grigsby IF, Macdonald PJ, Smith EM, Johnson JL, Rawson JM, Mansky LM, Mueller JD. Characterization of cytoplasmic Gag-gag interactions by dual-color z-scan fluorescence fluctuation spectroscopy. Biophysical Journal. 100: 1587-95. PMID 21402042 DOI: 10.1016/J.Bpj.2011.02.008 |
0.818 |
|
2011 |
Clouser CL, Holtz CM, Mullett M, Crankshaw DL, Briggs JE, Chauhan J, VanHoutan IM, Patterson SE, Mansky LM. Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine. Plos One. 6: e15840. PMID 21264291 DOI: 10.1371/Journal.Pone.0015840 |
0.785 |
|
2011 |
Dorr CR, Yemets S, Kolomitsyna O, Krasutsky P, Mansky LM. Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication. Bioorganic & Medicinal Chemistry Letters. 21: 542-5. PMID 21084190 DOI: 10.1016/J.Bmcl.2010.10.078 |
0.807 |
|
2011 |
Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms. Journal of Virology. 85: 43-50. PMID 20962093 DOI: 10.1128/Jvi.01774-10 |
0.424 |
|
2011 |
Fogarty KH, Chen Y, Grigsby IF, Macdonald PJ, Smith EM, Johnson JL, Rawson JM, Mueller JD, Mansky LM. Analysis of the HTLV-1 Gag assembly pathway by biophysical fluorescence Retrovirology. 8: A206. DOI: 10.1186/1742-4690-8-S1-A206 |
0.818 |
|
2011 |
Fogarty K, Johnson J, Grigsby I, MacDonald P, Chen Y, Rawson J, Mansky L, Mueller J. Brightness Analysis of Cytoplasmic HTLV-1 and HIV-1 Gag in the Presence of Membrane-Bound Gag Complexes by Dual-Color Z-Scan Fluorescence Fluctuation Spectroscopy Biophysical Journal. 100: 468a. DOI: 10.1016/J.Bpj.2010.12.2747 |
0.81 |
|
2010 |
Grigsby IF, Zhang W, Johnson JL, Fogarty KH, Chen Y, Rawson JM, Crosby AJ, Mueller JD, Mansky LM. Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry. Retrovirology. 7: 75. PMID 20854688 DOI: 10.1186/1742-4690-7-75 |
0.789 |
|
2010 |
Clouser CL, Patterson SE, Mansky LM. Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of Virology. 84: 9301-9. PMID 20610712 DOI: 10.1128/Jvi.01006-10 |
0.68 |
|
2010 |
Sadler HA, Stenglein MD, Harris RS, Mansky LM. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. Journal of Virology. 84: 7396-404. PMID 20463080 DOI: 10.1128/Jvi.00056-10 |
0.536 |
|
2010 |
Fogarty K, Grigsby I, Wang X, Chen Y, Rawson J, Mueller J, Mansky L. Characterization of Retroviral Gag Behavior in the Cytoplasm of Living Cells Using Fluorescence Fluctuation Spectroscopy Biophysical Journal. 98: 655a-656a. DOI: 10.1016/J.Bpj.2009.12.3595 |
0.843 |
|
2009 |
Dapp MJ, Clouser CL, Patterson S, Mansky LM. 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8. PMID 19726509 DOI: 10.1128/Jvi.01406-09 |
0.837 |
|
2009 |
Chen Y, Wu B, Musier-Forsyth K, Mansky LM, Mueller JD. Fluorescence fluctuation spectroscopy on viral-like particles reveals variable Gag stoichiometry Biophysical Journal. 96: 1961-1969. PMID 19254556 DOI: 10.1016/J.Bpj.2008.10.067 |
0.669 |
|
2009 |
Ni Z, Knorr DA, Clouser CL, Southern P, Mansky LM, Park I, Kaufman DS. Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection. Blood. 114: 280-280. DOI: 10.1182/Blood.V114.22.280.280 |
0.359 |
|
2007 |
Mbisa JL, Barr R, Thomas JA, Vandegraaff N, Dorweiler IJ, Svarovskaia ES, Brown WL, Mansky LM, Gorelick RJ, Harris RS, Engelman A, Pathak VK. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. Journal of Virology. 81: 7099-110. PMID 17428871 DOI: 10.1128/Jvi.00272-07 |
0.355 |
|
2006 |
Haché G, Mansky LM, Harris RS. Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance. Aids Reviews. 8: 148-57. PMID 17078485 |
0.415 |
|
2005 |
Chen R, Yokoyama M, Sato H, Reilly C, Mansky LM. Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. Journal of Virology. 79: 12045-57. PMID 16140780 DOI: 10.1128/Jvi.79.18.12045-12057.2005 |
0.368 |
|
2005 |
Jewell NA, Mansky LM. Construction and characterization of deltaretrovirus indicator cell lines. Journal of Virological Methods. 123: 17-24. PMID 15582694 DOI: 10.1016/j.jviromet.2004.09.002 |
0.321 |
|
2005 |
Chen R, Quinones-Mateu ME, Mansky LM. HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment. Frontiers in Bioscience : a Journal and Virtual Library. 10: 743-50. PMID 15569614 DOI: 10.2741/1568 |
0.359 |
|
2004 |
Chen R, Quinones-Mateu ME, Mansky LM. Drug resistance, virus fitness and HIV-1 mutagenesis. Current Pharmaceutical Design. 10: 4065-70. PMID 15579088 DOI: 10.2174/1381612043382404 |
0.347 |
|
2004 |
Chen R, Le Rouzic E, Kearney JA, Mansky LM, Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. The Journal of Biological Chemistry. 279: 28419-25. PMID 15096517 DOI: 10.1074/Jbc.M403875200 |
0.425 |
|
2004 |
Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry. 43: 4490-500. PMID 15078095 DOI: 10.1021/Bi035258R |
0.378 |
|
2003 |
Jewell NA, Chen R, Raices R, Mansky LM. Nucleoside reverse transcriptase inhibitors and HIV mutagenesis. The Journal of Antimicrobial Chemotherapy. 52: 547-50. PMID 12951341 DOI: 10.1093/Jac/Dkg387 |
0.389 |
|
2003 |
Mansky LM. Mutagenic outcome of combined antiviral drug treatment during human immunodeficiency virus type 1 replication. Virology. 307: 116-21. PMID 12667819 DOI: 10.1016/S0042-6822(02)00069-7 |
0.428 |
|
2003 |
Mansky LM, Le Rouzic E, Benichou S, Gajary LC. Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 77: 2071-80. PMID 12525642 DOI: 10.1128/JVI.77.3.2071-2080.2003 |
0.478 |
|
2002 |
Mansky LM. HIV mutagenesis and the evolution of antiretroviral drug resistance. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 5: 219-23. PMID 12531178 DOI: 10.1016/S1368-7646(02)00118-8 |
0.337 |
|
2002 |
Mansky LM, Pearl DK, Gajary LC. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. Journal of Virology. 76: 9253-9. PMID 12186909 DOI: 10.1128/Jvi.76.18.9253-9259.2002 |
0.38 |
|
2002 |
Wang H, Norris KM, Mansky LM. Analysis of bovine leukemia virus gag membrane targeting and late domain function. Journal of Virology. 76: 8485-93. PMID 12134053 DOI: 10.1128/Jvi.76.16.8485-8493.2002 |
0.338 |
|
2001 |
Mansky LM, Preveral S, Le Rouzic E, Bernard LC, Selig L, Depienne C, Benarous R, Benichou S. Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology. 282: 176-85. PMID 11259200 DOI: 10.1006/viro.2000.0791 |
0.467 |
|
2000 |
Mansky LM, Cunningham KS. Virus mutators and antimutatorsroles in evolution, pathogenesis and emergence Trends in Genetics. 16: 512-517. PMID 11074294 DOI: 10.1016/S0168-9525(00)02125-9 |
0.306 |
|
2000 |
Mansky LM, Bernard LC. 3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1. Journal of Virology. 74: 9532-9. PMID 11000223 DOI: 10.1128/JVI.74.20.9532-9539.2000 |
0.449 |
|
2000 |
Mansky LM. In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy Journal of Virology. 74: 9525-9531. PMID 11000222 DOI: 10.1128/JVI.74.20.9525-9531.2000 |
0.428 |
|
2000 |
Mansky LM, Preveral S, Selig L, Benarous R, Benichou S. The interaction of Vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate Journal of Virology. 74: 7039-7047. PMID 10888643 DOI: 10.1128/JVI.74.15.7039-7047.2000 |
0.484 |
|
1996 |
Mansky LM. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line Aids Research and Human Retroviruses. 12: 307-314. PMID 8906991 |
0.412 |
|
1996 |
Mansky LM. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene Virology. 222: 391-400. PMID 8806523 DOI: 10.1006/viro.1996.0436 |
0.412 |
|
1995 |
Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase Journal of Virology. 69: 5087-5094. PMID 7541846 DOI: 10.1128/Jvi.69.8.5087-5094.1995 |
0.482 |
|
1994 |
Mansky LM, Temin HM. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus Journal of Virology. 68: 494-499. PMID 8254760 DOI: 10.1128/Jvi.68.1.494-499.1994 |
0.316 |
|
Show low-probability matches. |